These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2143883)

  • 1. Macrophage histology in paraffin-embedded multiple sclerosis plaques is demonstrated by the monoclonal pan-macrophage marker HAM-56: correlation with chronicity of the lesion.
    Adams CW; Poston RN
    Acta Neuropathol; 1990; 80(2):208-11. PubMed ID: 2143883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis.
    Adams CW; Poston RN; Buk SJ
    J Neurol Sci; 1989 Sep; 92(2-3):291-306. PubMed ID: 2809622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte/macrophage differentiation in early multiple sclerosis lesions.
    Brück W; Porada P; Poser S; Rieckmann P; Hanefeld F; Kretzschmar HA; Lassmann H
    Ann Neurol; 1995 Nov; 38(5):788-96. PubMed ID: 7486871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages in multiple sclerosis.
    Brück W; Sommermeier N; Bergmann M; Zettl U; Goebel HH; Kretzschmar HA; Lassmann H
    Immunobiology; 1996 Oct; 195(4-5):588-600. PubMed ID: 8933159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques.
    Li H; Newcombe J; Groome NP; Cuzner ML
    Neuropathol Appl Neurobiol; 1993 Jun; 19(3):214-23. PubMed ID: 7689189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage populations associated with multiple sclerosis plaques.
    Esiri MM; Reading MC
    Neuropathol Appl Neurobiol; 1987; 13(6):451-65. PubMed ID: 3328828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia-derived macrophages in early multiple sclerosis plaques.
    Li H; Cuzner ML; Newcombe J
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):207-15. PubMed ID: 8804022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains.
    Zhang Z; Zhang ZY; Schittenhelm J; Wu Y; Meyermann R; Schluesener HJ
    J Neuroimmunol; 2011 Aug; 237(1-2):73-9. PubMed ID: 21737148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of tartrate-resistant acid phosphatase in human placenta.
    Janckila AJ; Yaziji H; Lear SC; Martin AW; Yam LT
    Histochem J; 1996 Mar; 28(3):195-200. PubMed ID: 8735286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study.
    Lee SC; Moore GR; Golenwsky G; Raine CS
    J Neuropathol Exp Neurol; 1990 Mar; 49(2):122-36. PubMed ID: 2307980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunophenotyping of extramedullary myeloid cell tumors in paraffin-embedded tissue sections.
    Davey FR; Olson S; Kurec AS; Eastman-Abaya R; Gottlieb AJ; Mason DY
    Am J Surg Pathol; 1988 Sep; 12(9):699-707. PubMed ID: 2970808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.
    Hauser SL; Bhan AK; Gilles F; Kemp M; Kerr C; Weiner HL
    Ann Neurol; 1986 Jun; 19(6):578-87. PubMed ID: 3524414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistological study of the immune system cells in paraffin-embedded tissues of conventional pigs.
    Chianini F; Majó N; Segalés J; Domínguez J; Domingo M
    Vet Immunol Immunopathol; 2001 Oct; 82(3-4):245-55. PubMed ID: 11587738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: involvement of interferons in lesion pathogenesis.
    Traugott U; Lebon P
    Ann Neurol; 1988 Aug; 24(2):243-51. PubMed ID: 2460022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of secondary-progressive multiple sclerosis.
    Prineas JW; Kwon EE; Cho ES; Sharer LR; Barnett MH; Oleszak EL; Hoffman B; Morgan BP
    Ann Neurol; 2001 Nov; 50(5):646-57. PubMed ID: 11706971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections.
    Wieczorek R; Buck D; Bindl J; Knowles DM
    Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
    Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
    Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor (M-CSF) and antigenic properties of macrophages in meningioma.
    Giometto B; Bozza F; Gallo P; Pagni S; Argentiero V; Ferla S; Mingrino S; Tavolato B
    J Neurooncol; 1992 May; 13(1):25-33. PubMed ID: 1377230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.